Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Gynecol Oncol ; 101(3): 487-94, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16406113

ABSTRACT

OBJECTIVE: To study the expression patterns of two different tumor suppressor proteins p16INK4A and p14ARF in cervical lesions. Both proteins are encoded by the same INK4A/ARF gene on chromosome 9p21. The expression patterns of these two proteins, both playing a central role in the cell cycle, were analyzed in detail in CIN, carcinomas, and normal epithelium to test the hypothesis that p16INK4A positive cells also demonstrate p14ARF expression. METHODS: Serial tissue sections of 9 CIN1 lesions, 10 CIN2 lesions, 12 CIN3 lesions, and 7 carcinomas were stained with monoclonal antibodies against p16INK4A and p14ARF. The short fragment polymerase chain reaction hybridization line probe assay was used to detect HPV. RESULTS: Normal epithelium was negative for both proteins. Marked immunoreactivity (++) for p16INK4A and p14ARF was observed in 5/7 carcinomas, 10/12 CIN3, and 1/10 CIN2 lesions and 0/9 CIN1 lesions. Simultaneous expression (+ or ++) was found in 19/22 CIN2/3 and not in CIN1 lesions. The fraction of p16INK4A-stained cells increased with CIN-grade. Overexpression of p14ARF was observed in a subpopulation of p16INK4A positive cells, and exclusively found in lesions infected with high-risk HPV. In two CIN3 lesions with early stromal invasion, p14ARF positivity was mainly found in the invasive cells. In carcinomas, all cells showed p16INK4A expression, whereas p14ARF was limited to the peripheral cells of the invasive tumor nests and individual migrating tumor cells. CONCLUSIONS: Overexpression of p14ARF is limited to a fraction of the p16INK4A-expressing cells and therefore it is likely that p14ARF- and p16INK4A expression are not induced by the same mechanisms. Before expression of p14ARF can be linked to invasion or invasive phenotype, larger series of (micro-) invasive squamous lesions need to be studied.


Subject(s)
Cyclin-Dependent Kinase Inhibitor p16/biosynthesis , Tumor Suppressor Protein p14ARF/biosynthesis , Uterine Cervical Dysplasia/metabolism , Uterine Cervical Neoplasms/metabolism , Cyclin-Dependent Kinase Inhibitor p16/genetics , Female , Humans , Immunohistochemistry , Papillomaviridae , Papillomavirus Infections/genetics , Papillomavirus Infections/metabolism , Tumor Suppressor Protein p14ARF/genetics , Uterine Cervical Neoplasms/genetics , Uterine Cervical Neoplasms/pathology , Uterine Cervical Neoplasms/virology , Uterine Cervical Dysplasia/genetics , Uterine Cervical Dysplasia/pathology , Uterine Cervical Dysplasia/virology
2.
Acta Cytol ; 48(5): 608-12, 2004.
Article in English | MEDLINE | ID: mdl-15471251

ABSTRACT

OBJECTIVE: To investigate whether the detection of proliferation-associated Ki-67 antigen may be of value in differentiating between reserve cell hyperplasia (RCH) and small cell lung cancer (SCLC). STUDY DESIGN: Retrospectively, 20 Papanicolaou-stained bronchial brushes or washings from 20 patients were selected. Ten were diagnosed as RCH (and had no SCLC in follow-up) and the other 10 as SCLC (histologically confirmed). All 20 Papanicolaou-stained slides were restained with the monoclonal antibody MIB1, directed against Ki-67 antigen; that simple and reliable procedure was described recently. In each specimen 5 coherent cell groups were identified, corresponding to RCH or SCLC, respectively; photographed; and studied for Ki-67 antigen expression after MIB1 staining of the slides. At least 3 cell groups remained in each specimen. The Ki-67 labeling index (LI) of the specimens was determined as the number of MIB1-positive cells divided by the total number of cells in the remaining cell groups. RESULTS: All cases of SCLC showed a mean Ki-67 LI of at least .415 (mean .684, SD .151), whereas in the cases with RCH the mean Ki-67 LI never was more than .158 (mean .048, SD .049). The difference was highly significant (P<.001, Student's t test). Linear discriminant analysis resulted in a classifier with which we were able to discriminate correctly between SCLC and RCH in 100% of the 20 bronchial brushings and washings. CONCLUSION: The results clearly demonstrate that measuring proliferative activity in Papanicolaou-stained bronchial brushings and washings by MIB1 restaining of the slides may be of great practical value in accurately discriminating RCH from SCLC. The method is simple and can be performed in any laboratory that is able to carry out immunocytochemical staining. However, an additional (prospective) study with a series of difficult cases is necessary to confirm these findings.


Subject(s)
Biomarkers, Tumor/analysis , Carcinoma, Small Cell/pathology , Hyperplasia/pathology , Ki-67 Antigen/analysis , Lung Neoplasms/pathology , Lung/pathology , Antibodies, Monoclonal , Biomarkers, Tumor/metabolism , Bronchoalveolar Lavage/methods , Bronchoalveolar Lavage Fluid/cytology , Carcinoma, Small Cell/metabolism , Cell Nucleus/pathology , Diagnosis, Differential , Humans , Hyperplasia/metabolism , Immunohistochemistry/methods , Ki-67 Antigen/immunology , Ki-67 Antigen/metabolism , Lung/metabolism , Lung Neoplasms/metabolism , Predictive Value of Tests , Reproducibility of Results , Retrospective Studies
3.
Oral Oncol ; 40(4): 364-71, 2004 Apr.
Article in English | MEDLINE | ID: mdl-14969815

ABSTRACT

Tumors of different metastatic behavior possibly differ in genomic constitution. We identified molecular cytogenetic differences between a group of metastasized and nonmetastasized primary tongue tumors by comparative genomic hybridization. Most frequent chromosome copy number changes for metastasized and nonmetastasized tumors were +8q (100% and 71%, respectively) and +3q (56% and 43%, respectively). Metastasized tumors showed significantly more chromosome copy number changes than nonmetastasized tumors. High copy number gains were exclusively found in metastasized tumors for 3q23-qter, 5p, 12p and 13q21-q22. Genomic imbalances occurring in metastasized tumors but not in nonmetastasized tumours were +7q21 (44%), +14q (33%), and -15q (33%). The genetic constitution of primary tongue tumors that metastasize differs from tongue tumors that do not metastasize. Our data, although obtained from a relative small group of tumors, spotlights copy number gain of chromosome region 7q21 as a potential marker for metastatic behavior.


Subject(s)
Carcinoma, Squamous Cell/genetics , Carcinoma, Squamous Cell/secondary , Chromosome Aberrations , Tongue Neoplasms/genetics , Carcinoma, Squamous Cell/pathology , Female , Genetic Predisposition to Disease , Humans , Male , Neoplasm Metastasis/genetics , Nucleic Acid Hybridization , Tongue Neoplasms/pathology
4.
Cancer ; 99(5): 263-71, 2003 Oct 25.
Article in English | MEDLINE | ID: mdl-14579292

ABSTRACT

BACKGROUND: The objective of the current study was to evaluate the applicability of liquid-based cytology in the Netherlands population screening program for cervical cancer. METHODS: A special committee performed an evaluation of all the available literature. Two methods were investigated: the AutoCytePrep system (currently known as ShurePath-system; TriPath Imaging, Burlington, NC) and the ThinPrep system (Cytyc, Boxborough, MA) for the detection of squamous epithelial abnormalities. All literature up to May 2000 was evaluated. RESULTS: For the AutoCytePrep system, there were indications that the detection rate for atypical squamous cells of undetermined significance (ASCUS) or higher had lower sensitivity compared with conventional screening. No definitive statement could be made concerning the value of the AutoCytePrep system for the detection rate of low-grade squamous intraepithelial lesions (LSIL) or higher and high-grade squamous intraepithelial lesions (HSIL) or higher because of conflicting results. For the ThinPrep system, there were indications that the detection rate of ASCUS or higher had a higher detection rate compared with conventional screening, with slightly lower specificity. It is likely that the detection rate of LSIL or higher with the ThinPrep system had greater sensitivity compared with conventional screening with almost unchanged specificity. In addition, it is likely that the detection rate of HSIL or higher with the ThinPrep system had a higher detection rate and greater absolute sensitivity compared with conventional screening with almost unchanged relative and absolute specificity. CONCLUSIONS: Further research that complies with the standards stated in the current study will be necessary to evaluate the applicability of the AutoCytePrep method. Further evaluation of the costs and benefits of the ThinPrep method should be undertaken to decide definitively whether to implement this method in the Netherlands population screening program.


Subject(s)
Mass Screening/organization & administration , Uterine Cervical Neoplasms/pathology , Vaginal Smears/methods , Cytodiagnosis , Evidence-Based Medicine , Female , Humans , Netherlands , Reagent Kits, Diagnostic , Sensitivity and Specificity , Uterine Cervical Neoplasms/prevention & control
5.
Int J Cancer ; 102(2): 148-51, 2002 Nov 10.
Article in English | MEDLINE | ID: mdl-12385010

ABSTRACT

We assessed prospectively whether residual cervical intraepithelial neoplasia (CIN) after treatment for high-grade CIN can be predicted by genotype-specific high-risk HPV (HR-HPV) detection in follow-up cervical scrapes. A broad spectrum, highly sensitive SPF(10)-LiPA-PCR HPV detection technique was used on cervical scrapes before large loop excision of the transformation zone (LLETZ), on the LLETZ biopsy and on follow-up scrapes of 90 patients treated for high-grade CIN. HR-HPV was detected in the biopsies of 93% (n = 84) of the patients and in the follow-up scrapes of 48% (n = 43) of the patients. In 12 patients, genotype-specific HR-HPV persistence was detected in both follow-up scrapes. In 10 patients, residual CIN was detected. In 5 of these patients (including all patients with residual CIN 3), the follow-up scrapes showed genotype-specific HR-HPV persistence. In 2 patients, a different HR-HPV was detected, and 3 patients had HR-HPV-negative follow-up scrapes. Conventional cytologic follow-up was abnormal in 13 patients including all 10 patients with residual CIN. The negative predictive value (NPV) of HR-HPV detection on follow-up scrapes was high (94%). Repeat detection of genotype-specific HR-HPV showed a lower sensitivity and NPV than repeat detection of any HR-HPV, but its specificity was higher. Repeat conventional cytologic follow-up showed the highest sensitivity and NPV. In conclusion, the presence of HR-HPV in cervical scrapes after LLETZ for high-grade CIN is a risk factor for the presence of residual CIN. HR-HPV genotype-specific persistence is specifically present in patients with residual CIN 3. However, HR-HPV detection cannot predict or exclude the presence of residual CIN in the individual patient and additional procedures remain necessary.


Subject(s)
Papillomaviridae/isolation & purification , Uterine Cervical Dysplasia/diagnosis , Uterine Cervical Neoplasms/diagnosis , Female , Genotype , Humans , Neoplasm, Residual , Papillomaviridae/classification , Papillomaviridae/genetics , Prospective Studies , Sensitivity and Specificity , Uterine Cervical Neoplasms/pathology , Uterine Cervical Neoplasms/virology , Uterine Cervical Dysplasia/pathology , Uterine Cervical Dysplasia/virology
6.
J Pathol ; 198(3): 300-9, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12375262

ABSTRACT

The aims of this study were to assess the relationships between numerical aberrations of chromosome 1 and the presence of high-risk human papillomavirus (HPV). Five normal samples, 11 CIN1, 13 CIN2, 18 CIN3, and nine carcinomas were studied by in situ hybridization (ISH), using a DNA probe for the centromere of chromosome 1 (cen#1) and a DNA probe cocktail for HPV types 16 and 18. A short fragment polymerase chain reaction hybridization line probe assay (SPF-PCR-LiPA) technique was used to detect 25 HPV types. The mean number of cen#1 per nucleus (chromosome index, CI) was measured, and the fractional areas of dysplastic epithelium with HPV16/18 infection and with cen#1 aneusomy were estimated. Disomy was found in all normal epithelium and in 36% of CIN1. Tetrasomy was observed in 64% of CIN1, 15% of CIN2, and 17% of CIN3. Hyper-tetrasomy was observed in 77% of CIN2, 83% of CIN3, and 100% of invasive carcinomas. High-risk HPVs were present in 20%, 75%, and 94% of disomic, tetrasomic, and hyper-tetrasomic lesions, respectively. The mean CI value was significantly higher in the lesions infected with high-risk HPV than in the lesions not infected by high-risk HPV (p < 0.001), due to the significantly higher prevalence of hyper-tetrasomy. The ISH study disclosed that HPV16/18 was exclusively found within dysplastically altered epithelium. The area with aneusomy is mostly enclosed within the area infected with HPV. In 83% of the HPV16/18-positive CIN lesions, the fractional area of HPV-infected epithelium was equal to, or larger than, the fractional area with aneusomy. In conclusion, aneusomy for chromosome 1 is strongly associated with high-grade CIN lesions and infection with high-risk HPV; it is likely that the occurrence of numerical aberrations of chromosome 1 is preceded by infection with high-risk HPV.


Subject(s)
Chromosome Aberrations , Chromosomes, Human, Pair 1/genetics , Papillomaviridae/isolation & purification , Uterine Cervical Dysplasia/genetics , Uterine Cervical Neoplasms/genetics , Female , Humans , In Situ Hybridization/methods , Neoplasm Invasiveness , Papillomaviridae/classification , Papillomavirus Infections/complications , Papillomavirus Infections/virology , Polymerase Chain Reaction/methods , Tumor Virus Infections/complications , Tumor Virus Infections/virology , Uterine Cervical Neoplasms/pathology , Uterine Cervical Neoplasms/virology , Uterine Cervical Dysplasia/pathology , Uterine Cervical Dysplasia/virology
7.
Acta Cytol ; 46(4): 619-29, 2002.
Article in English | MEDLINE | ID: mdl-12146020

ABSTRACT

Based on the criteria of Wilson and Jungner and experiences in the population-based organized cervical screening program in the Netherlands, conditions for efficient and effective population screening for cervical cancer are described. The purpose of this paper is to determine if these criteria are met for cervical cancer screening and to give recommendations for improvement. Cervical cancer is still an important health problem; the present incidence reflects both background risk and screening activity during previous decades. A positive effect of screening is reached because of the long development time of the disease and the ability of the Pap smear test to detect precancer and early, symptomatic disease. Considerable reduction in the incidence and mortality of cervical cancers can be reached if all women attend and all detected lesions are adequately followed up. Common terminology and classification criteria for histology and cytology should be used. Whether newly developed techniques that may improve or replace cytology can be used in screening programs should be a multidisciplinary decision after clinical trials have given evidence-based information on the performance, cost-effectiveness and need of these techniques. When cervical cancer screening is undertaken, it should be offered in organized programs at the medical level closest to the patients, the general practitioner. High compliance is the most important factor in reducing cervical cancer incidence. Quality control and assurance must be performed at all levels. In the case of limited resources, the program should use a five-year interval and concentrate on the age range 25-60 years, with special attention to women who have never been screened or were screened > 10 years previously. Evaluation of medical and organizational aspects is mandatory. Cooperation between all involved parties is a prerequisite of creating a successful screening program.


Subject(s)
Mass Screening/standards , Quality Assurance, Health Care/standards , Uterine Cervical Neoplasms/diagnosis , Cost-Benefit Analysis/standards , Cytological Techniques/standards , Female , Humans , Netherlands/epidemiology , Patient Education as Topic , Quality Control , Risk , Uterine Cervical Neoplasms/epidemiology , Uterine Cervical Neoplasms/prevention & control
8.
Cytometry ; 47(4): 256-64, 2002 Apr 01.
Article in English | MEDLINE | ID: mdl-11933016

ABSTRACT

BACKGROUND: Acquisition of DNA ploidy histograms by image analysis may yield important information regarding the behavior of premalignant cervical lesions. Accurate selection of nuclei for DNA measurement is an important prerequisite for obtaining reliable data. Traditionally, manual selection of nuclei of diagnostic and reference cells is performed by an experienced cytotechnologist. In the present study, a method for the fully automated identification of nuclei of diploid epithelial reference cells in Feulgen- restained Papanicolaou (PAP) smears is described. METHODS: The automated procedure consists of a decision tree implemented on the measurement device, containing nodes with feature threshold values and multivariate discriminant functions. Nodes were constructed to recognize debris and inflammatory cells, as well as diploid and nondiploid epithelial cells of the uterine cervix. Evaluation of the classifier was performed by comparing resulting diploid integrated optical densities with those from manually selected reference cells. RESULTS AND CONCLUSION: On average, automatically acquired values deviated 2.4% from manually acquired values, indicating that the method described in this paper may be useful in cytometric practice.


Subject(s)
Cell Nucleus/ultrastructure , Cervix Uteri/pathology , Chromosomes/ultrastructure , Image Processing, Computer-Assisted/methods , Papanicolaou Test , Uterine Cervical Neoplasms/pathology , Vaginal Smears/methods , Algorithms , Cell Nucleus/pathology , Decision Support Systems, Clinical/instrumentation , Diploidy , Epithelial Cells/cytology , Epithelial Cells/pathology , Female , Humans , Image Processing, Computer-Assisted/instrumentation , Neoplasms, Squamous Cell/pathology , Observer Variation , Polyploidy , Reference Standards , Reproducibility of Results , Uterine Cervical Neoplasms/genetics , Vaginal Smears/instrumentation
SELECTION OF CITATIONS
SEARCH DETAIL
...